Kids Medical Systems
In the Mar 2019 quarter, revenue was ₹0.18 Cr, against ₹0.22 Cr a year earlier and net profit was −₹0.25 Cr, against −₹0.29 Cr a year earlier (compared with Mar 2018). Promoters held 55.41% of Kids Medical Systems in Mar 2025, unchanged from Sep 2024.
Peer Comparison
Healthcare › Healthcare Services › Hospital
| ₹8,233.50 | 56.66 | 1,18,385 Cr | 12.49 | 0.26% | 20.08% | 19.79% | 26,675 Cr | 2,171 Cr | |
| ₹638.55 | 85.14 | 83,993 Cr | 5.11 | 0.00% | 10.42% | 9.50% | 11,400 Cr | 906 Cr | |
| ₹862.20 | 57.56 | 83,919 Cr | 7.81 | 0.24% | 13.42% | 12.70% | 8,879 Cr | 1,457 Cr | |
| ₹677.30 | 110.13 | 59,038 Cr | 14.03 | 0.45% | 8.84% | 9.71% | 5,006 Cr | 363 Cr | |
| ₹758.50 | 54.65 | 57,264 Cr | 5.79 | 0.14% | 10.47% | 12.13% | 9,607 Cr | 1,070 Cr | |
| ₹1,301.60 | 62.91 | 34,996 Cr | 8.83 | 0.04% | 13.91% | 15.05% | 4,800 Cr | 552 Cr | |
| ₹1,709.40 | 42.80 | 34,933 Cr | 7.70 | 0.26% | 17.85% | 11.39% | 9,185 Cr | 816 Cr | |
Kids Medical Systems (this company) | — | — | — | — | — | — | — | 1 Cr | -1 Cr |
| Median 8 companies | ₹862.20 | 57.56 | 59,038 Cr | 7.81 | 0.24% | 13.42% | 12.13% | 9,032 Cr | 861 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Strengths
2- Company is almost debt free.
- Stock is trading at 0.78 times its book value
Weaknesses
2- Company has low interest coverage ratio.
- Company has a low return on equity of -0.41% over last 3 years.
Technical Indicators
Oscillators
Bullish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
Quarterly Results
| Particulars | Mar 2018 | Sep 2018 | Mar 2019 |
|---|---|---|---|
| Sales | 0.22 | 0.16 | 0.18 |
| Expenses | 0.45 | 0.24 | 0.42 |
| Operating Profit | -0.23 | -0.08 | -0.24 |
| OPM % | -104.55% | -50% | -133.33% |
| Other Income | 0 | 0 | 0 |
| Interest | 0.04 | 0 | 0.01 |
| Depreciation | 0.02 | 0 | 0 |
| PBT | -0.29 | -0.08 | -0.25 |
| Tax % | 0% | 0% | 0% |
| Net Profit | -0.29 | -0.08 | -0.25 |
| EPS (₹) | -0.41 | -0.11 | -0.35 |
Profit & Loss
| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|
| Sales | 2.24 | 0.51 | 0.34 | 0 | 0 | 0 |
| Expenses | 2.04 | 0.74 | 0.67 | 0.02 | 0.01 | 0.07 |
| Operating Profit | 0.2 | -0.23 | -0.33 | -0.02 | -0.01 | -0.07 |
| OPM % | 8.93% | -45.1% | -97.06% | — | — | — |
| Other Income | -0.01 | 0.04 | 0 | 0 | 0 | 0.01 |
| Interest | 0 | 0.05 | 0.01 | 0 | 0 | 0 |
| Depreciation | 0.07 | 0.04 | 0 | 0 | 0 | 0 |
| PBT | 0.12 | -0.28 | -0.34 | -0.02 | -0.01 | -0.06 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 0.12 | -0.29 | -0.34 | -0.02 | -0.01 | -0.06 |
| EPS (₹) | 99.17 | -0.41 | -0.48 | -0.03 | -0.01 | -0.08 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 7.09 | 7.09 | 7.09 | 7.09 | 7.09 |
| Reserves | 0.47 | 4.03 | 0.15 | 0.28 | 0.27 | 0.22 |
| Borrowings | 0.6 | 0.3 | 0.37 | 0.26 | 0.26 | 0.26 |
| Other Liabilities | 2.65 | 0.11 | 0.22 | 0.27 | 0.28 | 0.3 |
| Total Liabilities | 3.73 | 11.53 | 7.83 | 7.9 | 7.9 | 7.87 |
| Fixed Assets | 0.23 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 |
| CWIP | 2.48 | 3.54 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1.02 | 7.8 | 7.64 | 7.71 | 7.71 | 7.68 |
| Total Assets | 3.73 | 11.53 | 7.83 | 7.9 | 7.9 | 7.87 |
Cash Flow
| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|
| Operating | 2.27 | -9.49 | -0.12 | 0 | 0 | 0 |
| Investing | -2.49 | -1.08 | -0.01 | 0 | 0 | 0 |
| Financing | 0.6 | 10.37 | 0.06 | 0 | 0 | 0 |
| Net Cash Flow | 0.38 | -0.2 | -0.07 | 0 | 0 | 0.01 |
| Free Cash Flow | -0.23 | -10.55 | -0.12 | 0 | 0 | 0 |
| CFO/OP | 1,135 | 4,126 | 36 | 0 | 0 | 0 |
Ratios
| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|
| Debtor Days | 34.22 | 157 | 236 | — | — | — |
| Cash Conversion Cycle | 34.22 | 157 | 236 | — | — | — |
| Working Capital Days | -440 | 4,960 | 7,128 | — | — | — |
| ROCE % | — | -3.68% | -3.47% | — | -0.13% | -0.79% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Kids Medical Systems insights
44 extracted metrics + investor summaries across FY11–FY25.
Documents
Frequently Asked Questions about Kids Medical Systems
Where is Kids Medical Systems Ltd (KMSL) listed?
Which sector does Kids Medical Systems Ltd belong to?
Company Information
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/540812.md for Kids Medical Systems Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.